Princi Jain1, B K Tripathi2, B Gupta3, Bharti Bhandari4, Divesh Jalan5. 1. Ex Resident, Department of Medicine, VMMC & SJH , New Delhi, India . 2. Professor, Department of Medicine, VMMC & SJH , New Delhi, India . 3. Ex Professor and Head, Department of Medicine, VMMC & SJH , New Delhi, India . 4. Assistant Professor, Department of Physiology, AIIMS , Jodhpur, India . 5. Assistant Professor, Department of Orthopaedics, AIIMS , Jodhpur, India .
Abstract
INTRODUCTION: Liver biopsy is considered as a gold standard for the diagnosis of cirrhosis. Till date there is no non-invasive marker to replace it. AIM: To investigate the effectiveness of Aspartate aminotransferase-to-platelet ratio index (APRI) as a non-invasive marker for liver cirrhosis. MATERIALS AND METHODS: Fifty-one patients with cirrhosis, identified on USG abdomen were included in study. Platelet count and Aspartate aminotransferase (AST) were done using haematology automatic analyser and automatic HITACHI-912 Auto Analyser respectively. APRI was calculated for every patient using the formula {(AST / ULN) x 100}/platelet count (10(9)/L). Predictive accuracy was evaluated with a receiver-operating characteristics (ROC) curve. RESULTS: APRI correctly classified 49 (96.1%) patients of cirrhosis with area under the ROC curve of 0.973 (95% CI) at cut-off 0.65 with negative predictive value (NPV) and Positive predictive value (PPV) of 96% and 96.1% respectively. The sensitivity and specificity of the test was found to be 96% and 96.1% respectively. CONCLUSION: APRI could identify cirrhosis with high degree of accuracy in the studied patients.
INTRODUCTION: Liver biopsy is considered as a gold standard for the diagnosis of cirrhosis. Till date there is no non-invasive marker to replace it. AIM: To investigate the effectiveness of Aspartate aminotransferase-to-platelet ratio index (APRI) as a non-invasive marker for liver cirrhosis. MATERIALS AND METHODS: Fifty-one patients with cirrhosis, identified on USG abdomen were included in study. Platelet count and Aspartate aminotransferase (AST) were done using haematology automatic analyser and automatic HITACHI-912 Auto Analyser respectively. APRI was calculated for every patient using the formula {(AST / ULN) x 100}/platelet count (10(9)/L). Predictive accuracy was evaluated with a receiver-operating characteristics (ROC) curve. RESULTS: APRI correctly classified 49 (96.1%) patients of cirrhosis with area under the ROC curve of 0.973 (95% CI) at cut-off 0.65 with negative predictive value (NPV) and Positive predictive value (PPV) of 96% and 96.1% respectively. The sensitivity and specificity of the test was found to be 96% and 96.1% respectively. CONCLUSION: APRI could identify cirrhosis with high degree of accuracy in the studied patients.
Authors: C Rinaldi A Lesmana; Simon Salim; Irsan Hasan; Andri S Sulaiman; Rino A Gani; Levina S Pakasi; Laurentius A Lesmana; Ening Krisnuhoni; Unggul Budihusodo Journal: J Clin Pathol Date: 2011-06-13 Impact factor: 3.411
Authors: Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok Journal: Hepatology Date: 2003-08 Impact factor: 17.425
Authors: Roberto J Carvalho-Filho; Leonardo L Schiavon; Janaína L Narciso-Schiavon; Juliana P Sampaio; Valéria P Lanzoni; Maria Lucia G Ferraz; Antonio Eduardo B Silva Journal: Liver Int Date: 2008-04 Impact factor: 5.828
Authors: W G Shin; S H Park; M K Jang; T H Hahn; J B Kim; M S Lee; D J Kim; S-Y Jun; C K Park Journal: Dig Liver Dis Date: 2007-12-04 Impact factor: 4.088